相关实验视频

Updated: Jul 5, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

p38 新一代多发性骨髓瘤治疗的分子向

Mario Morales-Martínez¹, Mario I Vega^1,2

¹Molecular Signal Pathway in Cancer Laboratory, UIMEO, Oncology Hospital, Siglo XXI National Medical Center, Mexican Institute of Social Security (IMSS), Mexico City 06720, Mexico.

|January 23, 2024

概括

p38基激活蛋白激酶 (p38) 信号驱动癌症治疗耐药性和进展. 向p38可能会逆转耐药性,并防止多发性骨髓瘤的疾病进展.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症信号通路癌症信号通路

背景情况:

治疗耐药性和疾病进展是癌症死亡的主要原因.
信号通路是治疗耐药性和癌症进展的关键媒介.
多发性骨髓瘤对各种癌症疗法具有抗性.

研究的目的:

审查最近关于p38基因激活蛋白激酶 (p38) 在多发性骨髓瘤中的作用的发现.
在癌症抵抗的背景下探索p38的表达,活性和异型.
讨论针对p38的潜在临床实用性,以克服治疗耐药性和预防进展.

主要方法:

关于多发性骨髓瘤中p38信号的最新研究的文献综述.
对调查p38表达和活性的研究进行分析.
对p38异构体及其在抗性机制中的作用的数据的检查.

主要成果:

p38信号通路与耐化疗,放射治疗和免疫治疗的耐药性有关.
最近的进展改善了对p38在多发性骨髓瘤进展中的作用的理解.
p38活性和异型是治疗耐药性的关键因素.

结论:

在多发性骨髓瘤中,p38信号是治疗耐药性和进展的重要因素.
针对p38的治疗策略显示出逆转化疗耐药性的前景.
对p38的临床作用进行进一步的研究是有必要的,以改善多发性骨髓瘤治疗.

关键词:

癌症进展癌症进展临床影响临床影响基因表达的基因表达方式多发性骨髓瘤是多发性骨髓瘤的一种.在p38中,p38是什么?转录因子转录因子

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...